185 related articles for article (PubMed ID: 37953237)
1. Novel biomarkers to predict treatment response and prognosis in locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.
Guan B; Xu M; Zheng R; Guan G; Xu B
BMC Cancer; 2023 Nov; 23(1):1099. PubMed ID: 37953237
[TBL] [Abstract][Full Text] [Related]
2. Predictive Value of the Neutrophil-Lymphocyte Ratio for Tumor Regression Grade and Prognosis of Local Advanced Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
Li S; Wang D; Wei R; Yu G; Wang X; Jiang Z
Technol Cancer Res Treat; 2023; 22():15330338231202611. PubMed ID: 37807729
[TBL] [Abstract][Full Text] [Related]
3. Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer.
Zhang Y; Yan L; Wu Y; Xu M; Liu X; Guan G
BMC Cancer; 2020 Sep; 20(1):854. PubMed ID: 32891131
[TBL] [Abstract][Full Text] [Related]
4. FOSL2 promotes intertumoral infiltration of T cells and increases pathological complete response rates in locally advanced rectal cancer patients.
Xu K; Yin X; Zhou B; Zheng X; Wang H; Chen J; Cai X; Gao H; Xu X; Wang L; Shen L; Guo T; Zheng S; Li B; Shao Y; Wang J
Cancer Lett; 2023 May; 562():216145. PubMed ID: 36997107
[TBL] [Abstract][Full Text] [Related]
5. An Immune-Related Gene Signature for Predicting Neoadjuvant Chemoradiotherapy Efficacy in Rectal Carcinoma.
Qian L; Lai X; Gu B; Sun X
Front Immunol; 2022; 13():784479. PubMed ID: 35603163
[TBL] [Abstract][Full Text] [Related]
6. A nomogram for predicting good response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer: a retrospective, double-center, cohort study.
Wang G; Zheng Z; Chen J; Ye J; Tang Z; Fang Y; Yao K; Zeng Q; Yang Y; Tang H; Lin B; Guo Y; Huang Y
Int J Colorectal Dis; 2022 Oct; 37(10):2157-2166. PubMed ID: 36048198
[TBL] [Abstract][Full Text] [Related]
7. A deep neural network predictor to predict the sensitivity of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Liu Y; Shi J; Liu W; Tang Y; Shu X; Wang R; Chen Y; Shi X; Jin J; Li D
Cancer Lett; 2024 May; 589():216641. PubMed ID: 38232812
[TBL] [Abstract][Full Text] [Related]
8. Genetic variations using whole-exome sequencing might predict response for neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Lee IH; Kang K; Kang BW; Lee SJ; Bae WK; Hwang JE; Kim HJ; Park SY; Park JS; Choi GS; Kim JG
Med Oncol; 2018 Sep; 35(11):145. PubMed ID: 30206710
[TBL] [Abstract][Full Text] [Related]
9. The prognostic role of TCF4 expression in locally advanced rectal cancer patients treated with neoadjuvant chemoradiotherapy.
Dou X; Wang R; Meng X; Yan H; Jiang S; Zhu K; Xu X; Chen D; Song X; Mu D
Cancer Biomark; 2015; 15(2):181-8. PubMed ID: 25519018
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of mesorectal package area in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy: A retrospective cohort study.
Guan B; Huang X; Xia H; Guan G; Xu B
Front Oncol; 2022; 12():941786. PubMed ID: 36263216
[TBL] [Abstract][Full Text] [Related]
11. Locally advanced rectal cancer transcriptomic-based secretome analysis reveals novel biomarkers useful to identify patients according to neoadjuvant chemoradiotherapy response.
Canto LMD; Cury SS; Barros-Filho MC; Kupper BEC; Begnami MDFS; Scapulatempo-Neto C; Carvalho RF; Marchi FA; Olsen DA; Madsen JS; Havelund BM; Aguiar S; Rogatto SR
Sci Rep; 2019 Jun; 9(1):8702. PubMed ID: 31213644
[TBL] [Abstract][Full Text] [Related]
12. A good preoperative immune prognostic index is precits a better prognosis for locally advanced rectal cancer patients with ypTNM stage II who underwent radical resection after neoadjuvant chemoradiotherapy.
Li S; Wang Y; Cai H; Pan Z; Guan G
Int J Colorectal Dis; 2023 Jul; 38(1):184. PubMed ID: 37395868
[TBL] [Abstract][Full Text] [Related]
13. GOLPH3 overexpression correlates with poor response to neoadjuvant therapy and prognosis in locally advanced rectal cancer.
Zhu K; Zhao Q; Yue J; Shi P; Yan H; Xu X; Wang R
Oncotarget; 2016 Oct; 7(42):68328-68338. PubMed ID: 27634904
[TBL] [Abstract][Full Text] [Related]
14. Worse prognosis in young patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy: A comparative study.
Zhang Y; Wang Y; Liu X; Chen B; Zhuang J; Li S; Yang Y; Su Y; Guan G
Medicine (Baltimore); 2020 Aug; 99(35):e21304. PubMed ID: 32871861
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of neoadjuvant rectal score in locally advanced rectal cancer after neoadjuvant chemoradiotherapy and construction of a prediction model.
Sun Y; Zhang Y; Wu X; Lin H; Lu X; Huang Y; Xu Z; Huang S; Wang X; Chi P
J Surg Oncol; 2018 Mar; 117(4):737-744. PubMed ID: 29228455
[TBL] [Abstract][Full Text] [Related]
16. Somatic Mutations and Immune Alternation in Rectal Cancer Following Neoadjuvant Chemoradiotherapy.
Ji D; Yi H; Zhang D; Zhan T; Li Z; Li M; Jia J; Qiao M; Xia J; Zhai Z; Song C; Gu J
Cancer Immunol Res; 2018 Nov; 6(11):1401-1416. PubMed ID: 30282671
[TBL] [Abstract][Full Text] [Related]
17. The prognostic role of EZH2 expression in rectal cancer patients treated with neoadjuvant chemoradiotherapy.
Meng X; Huang Z; Wang R; Jiao Y; Li H; Xu X; Feng R; Zhu K; Jiang S; Yan H; Yu J
Radiat Oncol; 2014 Aug; 9():188. PubMed ID: 25159232
[TBL] [Abstract][Full Text] [Related]
18. High Expression of VSTM2L Induced Resistance to Chemoradiotherapy in Rectal Cancer through Downstream IL-4 Signaling.
Liu H; Zhang Z; Zhen P; Zhou M
J Immunol Res; 2021; 2021():6657012. PubMed ID: 33506057
[TBL] [Abstract][Full Text] [Related]
19. Identification of proteins associated with treatment response of neoadjuvant chemoradiotherapy in rectal mucinous adenocarcinoma by co-expression network analysis based on proteomic analysis.
Sun Y; Lin Y; Deng Y; Wu X; Zhong J; Huang Y; Jiang W; Chi P
J Proteomics; 2022 Mar; 254():104472. PubMed ID: 34990823
[TBL] [Abstract][Full Text] [Related]
20. Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study.
Yi Y; Shen L; Shi W; Xia F; Zhang H; Wang Y; Zhang J; Wang Y; Sun X; Zhang Z; Zou W; Yang W; Zhang L; Zhu J; Goel A; Ma Y; Zhang Z
Clin Cancer Res; 2021 Mar; 27(5):1329-1340. PubMed ID: 33298472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]